
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 23
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT03480373 | Electronic Cigarette Use During Pregnancy | ||
NCT02851004 | Special Combination of BBI608 and Pembrolizumab | ||
NCT04417192 | Olaparib Monotherapy and Olaparib + Pembrolizumab Combination Therapy for Ovarian Cancer | ||
NCT06043921 | Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel | ||
NCT02410369 | Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer | ||
NCT03000751 | CT DOSE Collaboratory | ||
NCT05694819 | Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) | ||
NCT03172819 | Special Combination of OBP-301 and Pembrolizumab | ||
NCT02948348 | Study to Nivolumab Following Preoperative Chemoradiotherapy | ||
NCT05696548 | Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION) | ||
NCT04745988 | An Open Label Phase 2 Study to Evaluate the Safety and Efficacy of Lenvatinib with Pembrolizumab or Lenvatinib, Pembrolizumab and FLOT in the Neoadjuvant / Adjuvant Treatment for Patients with Gastric Cancer | ||
NCT07018570 | An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma | ||
NCT03609359 | Lenvatinib and Pembrolizumab Simultaneous Combination Study | ||
NCT04288999 | Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer | ||
NCT04879368 | RegoNivo vs Standard of Care Chemotherapy in AGOC | ||
NCT04740372 | Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | ||
NCT04465968 | Efficacy and Safety of CRT, Durvalumab and Surgery for SST | ||
NCT05394740 | Clinical Study of Regorafenib and Nivolumab Plus Chemotherapy | ||
NCT05646511 | TNT of SCRT+CAPOX vs SCRT+CAPOXIRI for Locally Advanced Rectal Cancer | ||
NCT05034887 | Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients with HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma | ||
NCT03406871 | Regorafenib and Nivolumab Simultaneous Combination Therapy | ||
NCT04040361 | Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) | ||
NCT04457297 | Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection |